Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Challenges and opportunities in animal drug development: a regulatory perspective

Nature Reviews Drug Discovery volume 2, pages 915–919 (2003)Cite this article

Abstract

Veterinary drugs are important in maintaining the health and productivity of agricultural animals, and the health of companion animals. Although there are many parallels between the development of animal drugs and human drugs, there are also important differences. This article focuses on some key challenges and opportunities for veterinary drug development in the light of the regulatory framework for animal healthcare.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Wood Mackenzie. Animal Health Service (Wood Mackenzie, Edinburgh, 2002).

  2. Evans, T. & Chapple, N. The animal health market. Nature Rev. Drug Discov. 1, 937–938 (2002).

    Article  CAS  Google Scholar 

  3. 21 CFR 510.3.

  4. Title 21, Chapter 9, Subchapter V, Part A, Section 360b.

  5. Animal Drug Availability Act [online] (cited 1 May 2002) <http://www.fda.gov/cvm/index/adaa/adaa66.pdf> (1996).

  6. CVM Update [online] (cited 1 May 2002) <http://www.fda.gov/cvm/index/updates/adaa.html> (1996).

  7. Animal Medicinal Drug Use Clarification Act [online] (cited 1 May 2002) <http://www.fda.gov/cvm/index/amducca/amducatoc.htm> (1994).

  8. Federal Food, Drug and Cosmetic Act (21U. S. C. 301 et seq.).

  9. Federal Register 61, 57732–57746 (1996).

  10. 21 CFR part 530.

  11. Federal Register 62, 27944–27945 (1997).

  12. Minor Use and Minor Species Animal Health Act [online] (cited 1 May 2002) <http://www.fda.gov/cvm/index/mums/minortoc.htm> (2001).

  13. Generic Animal Drug Patent Term Restoration Act. [online] (cited 1 May 2002) <http://www.fda.gov/cvm/index/adaa/adaa66.pdf> (1996).

  14. CVMM-50 [online] (cited 1 May 2002) <http://www.fda.gov/cvm/index/memos/cvmm50.html> (1992).

  15. Martinez, M., Langston, C., Martin, T. & Conner, D. Challenges associated with the evaluation of veterinary product bioequivalence: an AAVPT perspective. J. Vet. Pharmacol. Ther. 25, 201–220 (2002).

    Article  CAS  Google Scholar 

  16. FDA Veterinarian XVII, 1–2 (Sept/Oct 2002).

  17. Teuber, M. Veterinary use and antibiotic resistance. Curr. Opin. Microbiol. 4, 493–499 (2001).

    Article  CAS  Google Scholar 

  18. U.S. Food and Drug Administration. A proposed framework for evaluating and assuring the human safety of the microbial effects of antimicrobial new animal drugs intended for use in food–producing animals. Federal Register Jan 6 (1999).

  19. FDA Guidance 152 'Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern' (2002).

  20. Singer, R. S., Finch, R., Wegener, H. C. & Bywater, R. Antibiotic resistance — the interplay between antibiotic use in animals and human beings. People, animals, and antibiotic resistance forum. Lancet Infect. Dis. 3, 47–51 (2003).

    Article  Google Scholar 

  21. To ban or not to ban? Lancet Infect. Dis. 3, 1 (2003).

  22. Flower, R. J. The development of COX2 inhibitors. Nature Rev. Drug Discov. 2, 179–191 (2003).

    Article  CAS  Google Scholar 

  23. Johnston, S. A. & Budsberg, S. C. Nonsteroidal anti-inflammatory drugs and corticosteroids for the management of canine osteoarthritis. Vet. Clin. North. Am. Small Anim. Pract. 27, 841–862 (1997).

    Article  CAS  Google Scholar 

  24. Streppa, H. K., Jones, C. J. & Budsberg, S. C. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood. Am. J. Vet. Res. 63, 91–94 (2002).

    Article  CAS  Google Scholar 

  25. Ricketts, A. P. et al. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am. J. Vet. Res. 59, 1441–1446 (1998).

    CAS  PubMed  Google Scholar 

  26. Gierse, J. K. et al. Cloning, expression, and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2. Vet. Ther. 3, 270–280 (2002).

    PubMed  Google Scholar 

  27. Martel-Pelletier, J., Lajeunesse, D., Reboul, P. & Pelletier, J. P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann. Rheum. Dis. 62, 501–509 (2003).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. the Center for Veterinary Medicine, FDA, Office of the Director, HFV-1, 7519 Standish Place, Opinions are those of the author and do not represent policy of the FDA or the US Government, Rockville, 20855, Maryland, USA

    Claire M. Lathers

Authors
  1. Claire M. Lathers
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

DATABASES

LocusLink

COX-1

COX-2

FURTHER INFORMATION

Center for Veterinary Medicine

Office of New Animal Drug Evaluation

Veterinary International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lathers, C. Challenges and opportunities in animal drug development: a regulatory perspective. Nat Rev Drug Discov 2, 915–919 (2003). https://doi.org/10.1038/nrd1229

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd1229

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing